BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31606478)

  • 1. Where you live matters: Regional differences in health care resource use for psoriasis in the United States.
    Nguyen KB; Read C; Wu KK; Armstrong AW
    J Am Acad Dermatol; 2020 Jun; 82(6):1360-1367. PubMed ID: 31606478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does location matter? Geographic variations in healthcare resource use for atopic dermatitis in the United States.
    Wu KK; Nguyen KB; Sandhu JK; Armstrong AW
    J Dermatolog Treat; 2021 May; 32(3):314-320. PubMed ID: 31416361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.
    Murage MJ; Anderson A; Oliveria SA; Casso D; Ojeh CK; Muram TM; Merola JF; Araujo AB
    J Med Econ; 2018 Aug; 21(8):745-754. PubMed ID: 29718756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012.
    Tun K; Shurko JF; Ryan L; Lee GC
    PLoS One; 2018; 13(11):e0206893. PubMed ID: 30383858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare costs of acute and chronic tonsillar conditions in the pediatric population in the United States.
    Duarte VM; McGrath CL; Shapiro NL; Bhattacharrya N
    Int J Pediatr Otorhinolaryngol; 2015 Jun; 79(6):921-925. PubMed ID: 25912631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan.
    Armstrong AW; Zhao Y; Herrera V; Li Y; Bancroft T; Hull M; Altan A
    J Dermatolog Treat; 2017 Nov; 28(7):613-622. PubMed ID: 28320213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
    Joynt KE; Gawande AA; Orav EJ; Jha AK
    JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The direct cost of care for psoriasis and psoriatic arthritis in the United States.
    Javitz HS; Ward MM; Farber E; Nail L; Vallow SG
    J Am Acad Dermatol; 2002 Jun; 46(6):850-60. PubMed ID: 12063481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
    Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
    Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic and treatment patterns for infections in ambulatory settings in the United States, 2006-2010.
    May L; Mullins P; Pines J
    Acad Emerg Med; 2014 Jan; 21(1):17-24. PubMed ID: 24552520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.
    Blinder MA; Duh MS; Sasane M; Trahey A; Paley C; Vekeman F
    J Emerg Med; 2015 Oct; 49(4):513-522.e1. PubMed ID: 25910824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
    Al Sawah S; Foster SA; Goldblum OM; Malatestinic WN; Zhu B; Shi N; Song X; Feldman SR
    J Med Econ; 2017 Sep; 20(9):982-990. PubMed ID: 28635342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and resource use among psoriasis patients treated with biologics.
    Aleshaki JS; Cardwell LA; Muse ME; Feldman SR
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):609-617. PubMed ID: 30142007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The national cost of asthma among school-aged children in the United States.
    Sullivan PW; Ghushchyan V; Navaratnam P; Friedman HS; Kavati A; Ortiz B; Lanier B
    Ann Allergy Asthma Immunol; 2017 Sep; 119(3):246-252.e1. PubMed ID: 28890020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associated factors and costs of avoidable visits to the emergency department among cancer patients: 1-year experience in a tertiary care hospital in South Korea.
    Oh TK; Jo YH; Choi JW
    Support Care Cancer; 2018 Nov; 26(11):3671-3679. PubMed ID: 29740693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the burden of diabetes mellitus in emergency departments in the United States: the National Hospital Ambulatory Medical Care Survey (NHAMCS).
    Asao K; Kaminski J; McEwen LN; Wu X; Lee JM; Herman WH
    J Diabetes Complications; 2014; 28(5):639-45. PubMed ID: 24680472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender disparities in medical expenditures attributable to hypertension in the United States.
    Basu R; Franzini L; Krueger PM; Lairson DR
    Womens Health Issues; 2010; 20(2):114-25. PubMed ID: 20211429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Emergency Department Use by Rural and Urban Populations in the United States.
    Greenwood-Ericksen MB; Kocher K
    JAMA Netw Open; 2019 Apr; 2(4):e191919. PubMed ID: 30977849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.